Our study showed that survivors of COVID-19 had reduced brachial artery FMD compared with healthy control and risk factor-matched control, which is independent of severity of the illness, but inversely correlated with serum concentration of TNF-α after a median of 327 days from diagnosis. The gene discussed is TNF; the disease is COVID-19.